These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Lovell MA; Ehmann WD; Butler SM; Markesbery WR Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059 [TBL] [Abstract][Full Text] [Related]
6. Free radicals in the genesis of Alzheimer's disease. Richardson JS Ann N Y Acad Sci; 1993 Sep; 695():73-6. PubMed ID: 8239316 [TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Galbusera C; Facheris M; Magni F; Galimberti G; Sala G; Tremolada L; Isella V; Guerini FR; Appollonio I; Galli-Kienle M; Ferrarese C Curr Alzheimer Res; 2004 May; 1(2):103-9. PubMed ID: 15975074 [TBL] [Abstract][Full Text] [Related]
8. Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain. Andorn AC; Pappolla MA Free Radic Biol Med; 2001 Aug; 31(3):315-20. PubMed ID: 11461768 [TBL] [Abstract][Full Text] [Related]
9. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients. Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260 [TBL] [Abstract][Full Text] [Related]
10. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models. Gugliandolo A; Bramanti P; Mazzon E Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797 [TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Smith DG; Cappai R; Barnham KJ Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250 [TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Ramassamy C; Averill D; Beffert U; Bastianetto S; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Davignon J; Quirion R; Poirier J Free Radic Biol Med; 1999 Sep; 27(5-6):544-53. PubMed ID: 10490274 [TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Kabuto H; Yokoi I; Ogawa N Epilepsia; 1998 Mar; 39(3):237-43. PubMed ID: 9578039 [TBL] [Abstract][Full Text] [Related]
14. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls. Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224 [TBL] [Abstract][Full Text] [Related]
15. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. Subbarao KV; Richardson JS; Ang LC J Neurochem; 1990 Jul; 55(1):342-5. PubMed ID: 2355227 [TBL] [Abstract][Full Text] [Related]
16. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623 [TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain. Srivastava RA; Jain JC J Neurol Sci; 2002 Apr; 196(1-2):45-52. PubMed ID: 11959156 [TBL] [Abstract][Full Text] [Related]
19. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants. Di Domenico F; Barone E; Perluigi M; Butterfield DA Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342 [TBL] [Abstract][Full Text] [Related]